{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:36:50Z","timestamp":1761885410316,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.acuroe.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T02:32:57Z","timestamp":1668220377000},"page":"221-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"Territo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fontanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Meneghetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gallioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sanguedolce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3.","family":"Rodriguez-Faba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M","family":"Gaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Palou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2022.11.002_bib0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.acuro.2020.03.007","article-title":"Incidence of upper tract urothelial carcinoma in Spain","volume":"44","author":"Fernandez Aparicio","year":"2020","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.juro.2017.10.019","article-title":"Biological behavior and long-term outcomes of carcinoma in situ in upper urinary tract managed by radical nephroureterectomy","volume":"199","author":"Inamoto","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.juro.2016.03.194","article-title":"Upper urinary tract carcinoma in situ: Current knowledge, future direction","volume":"197","author":"Redrow","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-5347(05)66518-4","article-title":"The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder","volume":"165","author":"Kim","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2003.09.013","article-title":"Bladder carcinoma in situ in 2003: State of the art","volume":"45","author":"Witjes","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0035","doi-asserted-by":"crossref","first-page":"45.e23","DOI":"10.1016\/j.urolonc.2013.06.008","article-title":"Predicting response to bacillus Calmette-Gu\u00e9rin (BCG) in patients with carcinoma in situ of the bladder","volume":"32","author":"Nunez-Nateras","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0022-5347(17)38957-7","article-title":"Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ","volume":"142","author":"Studer","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1159\/000020365","article-title":"Bacillus Calmette-Gu\u00e9rin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract","volume":"38","author":"Nonomura","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1464-410X.2001.02297.x","article-title":"Intrarenal bacillus Calmette-Gu\u00e9rin therapy for carcinoma in situ of the upper urinary tract: Long-term follow-up and natural course in cases of failure","volume":"88","author":"Okubo","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0055","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.urology.2004.01.046","article-title":"Long-term effects of bacille Calmette-Gu\u00e9rin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract","volume":"63","author":"Hayashida","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1442-2042.2006.01312.x","article-title":"Long-term outcome of upper urinary tract carcinoma in situ: Effectiveness of nephroureterectomy versus bacillus Calmette-Gu\u00e9rin therapy","volume":"13","author":"Kojima","year":"2006","journal-title":"Int J Urol."},{"key":"10.1016\/j.acuroe.2022.11.002_bib0065","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","article-title":"Antegrade perfusion with bacillus Calmette-Gu\u00e9rin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: Who may benefit?","volume":"60","author":"Giannarini","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/07357907.2018.1430815","article-title":"Efficacy and tolerability of bacillus Calmette-Gu\u00e9rin therapy as the first-line therapy for upper urinary tract carcinoma in situ","volume":"36","author":"Tomisaki","year":"2018","journal-title":"Cancer Invest"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12032-018-1102-y","article-title":"Impact of bacillus Calmette-Gu\u00e9rin therapy of upper urinary tract carcinoma in situ: Comparison of oncological outcomes with radical nephroureterectomy","volume":"35","author":"Horiguchi","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-5347(17)36117-7","article-title":"Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ","volume":"149","author":"Sharpe","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.acuro.2016.04.001","article-title":"Conservative management and follow up in patients with upper tract urothelial carcinoma: Present or future?","volume":"40","author":"Ju\u00e1rez del Dago","year":"2016","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg."},{"key":"10.1016\/j.acuroe.2022.11.002_bib0095","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0022-5347(17)66369-9","article-title":"An operative technique for the correction of vesicoureteral reflux","volume":"79","author":"Politano","year":"1958","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0100","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1089\/end.2012.0229","article-title":"Outcomes of intrarenal Bacillus Calmette-Gu\u00e9rin\/interferon-\u03b12B for biopsy-proven upper-tract carcinoma in situ","volume":"26","author":"Shapiro","year":"2012","journal-title":"J Endourol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0105","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.juro.2018.02.002","article-title":"Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma","volume":"199","author":"Margolin","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","article-title":"Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: Implications for conservative management","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00345-016-1859-6","article-title":"Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: Treatment of low-risk upper tract urothelial carcinoma","volume":"35","author":"Mandalapu","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000444808","article-title":"Upper urinary tract urothelial carcinoma tumor seeding along percutaneous nephrostomy track: Case report and review of the literature","volume":"98","author":"Schwartzmann","year":"2017","journal-title":"Urol Int"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0125","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.radcr.2017.05.006","article-title":"Seeding of a high-grade papillary urothelial carcinoma of the bladder along a nephroureterostomy tract","volume":"12","author":"Gemender","year":"2017","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0130","doi-asserted-by":"crossref","DOI":"10.1177\/1756287219836895","article-title":"Is ureteral stent an effective way to deliver drugs such as bacillus Calmette-Gu\u00e9rin to the upper urinary tract? An experimental study","volume":"11","author":"Korkes","year":"2019","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00345-012-0949-3","article-title":"Upper urinary tract instillations in the treatment of urothelial carcinomas: A review of technical constraints and outcomes","volume":"31","author":"Audenet","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.acuroe.2022.11.002_bib0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2008.06.026","article-title":"A 20-year experience with percutaneous resection of upper tract transitional carcinoma: Is there an oncologic benefit with adjuvant bacillus Calmette Gu\u00e9rin therapy?","volume":"73","author":"Rastinehad","year":"2009","journal-title":"Urology"},{"issue":"4 Pt 1","key":"10.1016\/j.acuroe.2022.11.002_bib0145","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0022-5347(05)64454-0","article-title":"Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery","volume":"168","author":"Thalmann","year":"2002","journal-title":"J Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622001214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622001214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:15:45Z","timestamp":1761880545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578622001214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2173578622001214"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.11.002","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2022.10.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEU.","name":"copyright","label":"Copyright"}]}}